Log in

Relevant bibliographies by topics / Antithrombotic strategies, acute coronary syndrome, ST elevation acute myocardial infarction (STEMI), percutaneous coronary intervention

Contents

Journal articles

Academic literature on the topic 'Antithrombotic strategies, acute coronary syndrome, ST elevation acute myocardial infarction (STEMI), percutaneous coronary intervention'

Author: Grafiati

Published: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antithrombotic strategies, acute coronary syndrome, ST elevation acute myocardial infarction (STEMI), percutaneous coronary intervention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antithrombotic strategies, acute coronary syndrome, ST elevation acute myocardial infarction (STEMI), percutaneous coronary intervention"

1

Seker, Onur Osman, Idris Bugra Cerik, Metin Coksevim, Mustafa Yenercag, and Korhan Soylu. "Effectiveness of Different P2Y12 Inhibitors on Coronary Flow in Patients with ST-Elevation Myocardial Infarction." Journal Of Cardiovascular Emergencies 6, no. 4 (2020): 91–97. http://dx.doi.org/10.2478/jce-2020-0018.

Full text

Abstract:

Abstract Background: ST-segment elevation myocardial infarction (STEMI) is a clinical syndrome with high mortality. The main purpose of STEMI treatment is to achieve optimal revascularization for tissue perfusion. Besides the innovations in revascularization strategies, developments in antithrombotic therapy resulted in a significant reduction in STEMI-related mortality. Reperfusion can be demonstrated by resolution of ST-segment elevation (STR), TIMI frame count (TFC), and myocardial blush grade (MBG). Aim of the study: In our study, we investigated the effects of P2Y12 inhibitors clopidogrel

APA, Harvard, Vancouver, ISO, and other styles

2

Seker, Onur Osman, Idris Bugra Cerik, Metin Coksevim, Mustafa Yenercag, and Korhan Soylu. "Effectiveness of Different P2Y12 Inhibitors on Coronary Flow in Patients with ST-Elevation Myocardial Infarction." Journal Of Cardiovascular Emergencies 6, no. 4 (2020): 91–97. http://dx.doi.org/10.2478/jce-2020-0018.

Full text

Abstract:

AbstractBackground: ST-segment elevation myocardial infarction (STEMI) is a clinical syndrome with high mortality. The main purpose of STEMI treatment is to achieve optimal revascularization for tissue perfusion. Besides the innovations in revascularization strategies, developments in antithrombotic therapy resulted in a significant reduction in STEMI-related mortality. Reperfusion can be demonstrated by resolution of ST-segment elevation (STR), TIMI frame count (TFC), and myocardial blush grade (MBG). Aim of the study: In our study, we investigated the effects of P2Y12 inhibitors clopidogrel,

APA, Harvard, Vancouver, ISO, and other styles

3

Kireyev, Dmitriy, Huay Cheem Tan, and Kian Keong Poh. "Management of Acute ST-Elevation Myocardial Infarction: Reperfusion Options." Annals of the Academy of Medicine, Singapore 39, no. 12 (2010): 927–33. http://dx.doi.org/10.47102/annals-acadmedsg.v39n12p927.

Full text

Abstract:

Primary percutaneous coronary intervention and thrombolysis remain therapies of choice for patients presenting with ST-segment elevation myocardial infarction (STEMI). Clinical outcome in the management of acute STEMI is dependent on myocardial reperfusion time and reperfusion strategies. Optimisation of these strategies should take into consideration logistical limitations of the local medical systems and the various patient profiles. We review the reperfusion strategies and its history in Singapore, comparing its clinical application with that in some developed Western countries. Key words:

APA, Harvard, Vancouver, ISO, and other styles

4

Vlachojannis, Georgios J., Bimmer E. Claessen, and George D. Dangas. "Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction." Interventional Cardiology Review 7, no. 1 (2012): 33. http://dx.doi.org/10.15420/icr.2012.7.1.33.

Full text

Abstract:

Stent thrombosis (ST) is the most feared complication of coronary stent treatment because of its morbidity and mortality. Ongoing research is focusing on the frequency and the timing in various patient subsets as well as the factors associated with the occurrence of ST. The mechanism of ST is multifactorial, hence various procedure-, lesion- and patient-related factors have been associated with its occurrence. Beside these factors the role of adjunctive antithrombotic therapy remains unchallenged. Emerging data suggest that primary percutaneous coronary intervention for ST-elevation myocardial

APA, Harvard, Vancouver, ISO, and other styles

5

Kandan, Sri Raveen, and Thomas W. Johnson. "Contemporary Antiplatelet Strategies in the Treatment of STEMI using Primary Percutaneous Coronary Intervention." Interventional Cardiology Review 10, no. 1 (2015): 26. http://dx.doi.org/10.15420/icr.2015.10.1.26.

Full text

Abstract:

Reperfusion therapy for patients presenting with an acute ST-segment elevation myocardial infarction (STEMI) involves primary percutaneous coronary intervention (PPCI) and concomitant oral antiplatelet and intravenous antithrombotic pharmacotherapy. There is a conflict between the desire to reduce the time between first medical contact and coronary re-canalisation and achieving effective platelet inhibition with oral antiplatelet agents. This review outlines the currently available antiplatelet treatments, and their place within the therapeutic timeline of a patient presenting with STEMI. Addi

APA, Harvard, Vancouver, ISO, and other styles

6

Gilyarov, M. Yu, E. V. Konstantinova, M. R. Atabegashvili, et al. "Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome." Rational Pharmacotherapy in Cardiology 17, no. 2 (2021): 221–27. http://dx.doi.org/10.20996/1819-6446-2021-04-10.

Full text

Abstract:

Aim. To assess comorbidities in elderly patients with acute coronary syndrome (ACS) and to analyze patient subgroups with different treatment strategies in the Regional Vascular Center (RVC).Material and methods. The prospective study included 205 patients with confirmed ACS 75 years and older, the mean age was 81±4.9 years, and 68% were women. ST segment elevation myocardial infarction (STEMI) was diagnosed in 46 (22.4 %) patients, non-ST segment elevation myocardial infarction (NSTEMI) was diagnosed in 159 (77,6 %) patients. The Charlson Comorbidity Index (CCI) was calculated in every patien

APA, Harvard, Vancouver, ISO, and other styles

7

Thani, Khalid Bin, Fajer Al-Moosa, Eman Murad, Aisha Al-Moosa, Mohamed E. Alalawi, and Hind Al-Sindi. "Stent Thrombosis after Rescue Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction." Open Cardiovascular Medicine Journal 9, no. 1 (2015): 127–32. http://dx.doi.org/10.2174/1874192401509010127.

Full text

Abstract:

Main Problem:To determine the incidence of coronary stent thrombosis (ST) in patients with acute ST segment elevation myocardial infarction (STEMI) after rescue percutaneous coronary intervention (PCI). Methods:An observational study looking at the incidence of ST in a middle-eastern population. A total of 510 consecutive patients presented with ST-segment elevation myocardial infarction (STEMI) were enrolled and underwent thrombolytic therapy with a total follow-up period of 2 years. Study outcomes were ST, death, re-infarction or acute coronary syndrome requiring coronary angiography and PCI

APA, Harvard, Vancouver, ISO, and other styles

8

Zeymer, Uwe, Peter Ludman, Nicolas Danchin, et al. "The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry." European Heart Journal - Quality of Care and Clinical Outcomes 6, no. 2 (2019): 100–104. http://dx.doi.org/10.1093/ehjqcco/qcz042.

Full text

Abstract:

Abstract Aims The Acute Cardiac Care Association (ACCA)–European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI. Methods and results Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to th

APA, Harvard, Vancouver, ISO, and other styles

9

Fallahzadeh, Aida, Ali Sheikhy, Afsaneh Aein, et al. "Outcome of Percutaneous Coronary Intervention in Old Patients Presenting with Acute Coronary Syndrome." Archives of Iranian Medicine 25, no. 8 (2022): 523–32. http://dx.doi.org/10.34172/aim.2022.84.

Full text

Abstract:

Background: Octogenarians (age≥80 years) with coronary artery disease constitute a high-risk group and the elderly undergoing percutaneous coronary intervention (PCI) are at higher risk of adverse outcomes compared to young patients. In this study, we aimed to describe the outcomes of the elderly with acute coronary syndrome (ACS) who underwent PCI and also to identify the predictors of short-term major adverse cerebrocardiovascular events (MACCE) in octogenarians. Methods: In this registry-based cohort study, we reviewed the data of patients (aged≥65 years) who underwent PCI. Univariate Cox-r

APA, Harvard, Vancouver, ISO, and other styles

10

Kedev, Sasko. "The Role of the Transradial Approach for Complex Coronary Interventions in Patients with Acute Coronary Syndrome." Interventional Cardiology Review 8, no. 2 (2013): 81. http://dx.doi.org/10.15420/icr.2013.8.2.81.

Full text

Abstract:

Despite advances in antithrombotic and antiplatelet therapy, bleeding complications remain an important cause of morbidity and mortality in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). A significant proportion of such bleedings are related to the access site, and adoption of transradial access (TRA) may reduce these complications. In patients with ST-segment elevation myocardial infarction (STEMI), TRA reduced cardiac mortality in comparison with the femoral approach (TFA). High-risk patients such as women, obese patients and elderly subjects

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!